文献速递基础与转化研究新药、器械与细胞基因治疗研发

抗革兰阳性菌感染的候选抗生素可诱导多重耐药

Antibiotic candidates for Gram-positive bacterial infections induce multidrug resistance.
PubMed 文献 · Sci Transl Med · 2025-01-08

研究通过实验室进化探讨尚未上市的抗革兰阳性菌候选抗生素的耐药性演化。除化合物SCH79797外,金黄色葡萄球菌普遍容易对候选抗生素产生耐药,且与万古霉素、达托霉素及候选抗生素teixobactin存在交叉耐药,由调控系统突变的重叠分子机制驱动。teixobactin耐药菌表现出临床相关多重耐药并在无脊椎动物感染模型中保持毒力,候选抗生素的耐药突变已存在于自然细菌群体中。

要点

  • 除SCH79797外,金黄色葡萄球菌对候选抗生素普遍容易产生耐药。
  • 候选抗生素与万古霉素、达托霉素及teixobactin存在交叉耐药。
  • teixobactin耐药菌表现为临床相关多重耐药且在无脊椎动物感染模型中保持毒力。

核心结论

  • 除化合物SCH79797外,金黄色葡萄球菌对尚未上市的候选抗生素普遍容易产生耐药,且与临床在用抗生素及teixobactin存在交叉耐药。
  • teixobactin耐药菌表现出临床相关多重耐药并在无脊椎动物感染模型中保持毒力,候选抗生素的耐药突变已存在于自然细菌群体中。
  • 作者认为应在药物开发早期预测候选抗生素的未来耐药演化。

研究设计与样本

  • 对尚未上市的候选抗生素进行实验室耐药进化研究。

主要发现

  • 除化合物SCH79797外,金黄色葡萄球菌对候选抗生素普遍容易产生耐药。
  • 候选抗生素与万古霉素、达托霉素及候选抗生素teixobactin之间检测到交叉耐药。
  • 上述模式由调控系统突变导致的重叠分子机制驱动。
  • teixobactin耐药菌表现出临床相关多重耐药,并在无脊椎动物感染模型中保持毒力。
  • 针对候选抗生素的推定耐药突变已存在于自然细菌群体中。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Several antibiotic candidates are in development against Gram-positive bacterial pathogens, but their long-term utility is unclear. To investigate this issue, we studied the laboratory evolution of resistance to antibiotics that have not yet reached the market. We found that, with the exception of compound SCH79797, antibiotic resistance generally readily evolves in Staphylococcus aureus. Cross-resistance was detected between such candidates and antibiotics currently in clinical use, including vancomycin, daptomycin, and the promising antibiotic candidate teixobactin. These patterns were driven by overlapping molecular mechanisms through mutations in regulatory systems. In particular, teixobactin-resistant bacteria displayed clinically relevant multidrug resistance and retained their virulence in an invertebrate infection model, raising concerns. More generally, we demonstrate that putative resistance mutations against candidate antibiotics are already present in natural bacterial populations. Therefore, antibiotic resistance in nature may evolve readily from the selection of preexisting genetic variants. Our work highlights the importance of predicting future evolution of resistance to antibiotic candidates at an early stage of drug development.

来源:Sci Transl Med,查看原文。版权归原作者所有。

引用

  1. Martins A, Judák F, Farkas Z, et al. Antibiotic candidates for Gram-positive bacterial infections induce multidrug resistance. Sci Transl Med. 2025. PMID: 39772773. doi:10.1126/scitranslmed.adl2103

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。